Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADIT Pilot: Conventional vs Aggressive Antibiotics for Arrhythmia Device Infection
NCT01002911Phase 3Completed
- Sponsor
- Population Health Research Institute
- Start
- Dec 2009
- Primary completion
- Jan 2012
- Modality
- Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bacitracin and cefalexin in Cardiac Device Infection (CIEDI), sponsored by Population Health Research Institute. Primary endpoint: Hospitalization attributed to device infection at 12 months. Started Dec 2009; status: completed.
02
Drugs
bacitracincefalexin
03
Conditions
Cardiac Device Infection (CIEDI)
Beyond the preview
Go deeper on NCT01002911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002911.